Literature DB >> 15629299

Etiology and management of idiopathic orbital inflammation.

Peter A D Rubin, C Stephen Foster.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15629299     DOI: 10.1016/j.ajo.2004.09.032

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


× No keyword cloud information.
  15 in total

1.  Bilateral idiopathic orbital inflammatory syndrome with grossly elevated creatinine kinase levels.

Authors:  W H Chan; S Biswas; J Ashworth; I Hughes; V Sharma; I C Lloyd
Journal:  Eye (Lond)       Date:  2011-12-23       Impact factor: 3.775

2.  Factors associated with multiple recurrences of nonspecific orbital inflammation aka orbital pseudotumor.

Authors:  Puneet S Braich; Robin K Kuriakose; Naveen S Khokhar; Jared C Donaldson; Timothy J McCulley
Journal:  Int Ophthalmol       Date:  2017-06-20       Impact factor: 2.031

3.  Rituximab therapy for refractory orbital inflammation: results of a phase 1/2, dose-ranging, randomized clinical trial.

Authors:  Eric B Suhler; Lyndell L Lim; Robert M Beardsley; Tracy R Giles; Sirichai Pasadhika; Shelly T Lee; Alexandre de Saint Sardos; Nicholas J Butler; Justine R Smith; James T Rosenbaum
Journal:  JAMA Ophthalmol       Date:  2014-05       Impact factor: 7.389

4.  MR-based radiomics signature in differentiating ocular adnexal lymphoma from idiopathic orbital inflammation.

Authors:  Jian Guo; Zhenyu Liu; Chen Shen; Zheng Li; Fei Yan; Jie Tian; Junfang Xian
Journal:  Eur Radiol       Date:  2018-04-09       Impact factor: 5.315

5.  Orbital pseudotumor can be a localized form of granulomatosis with polyangiitis as revealed by gene expression profiling.

Authors:  James T Rosenbaum; Dongseok Choi; David J Wilson; Hans E Grossniklaus; Christina A Harrington; Cailin H Sibley; Roger A Dailey; John D Ng; Eric A Steele; Craig N Czyz; Jill A Foster; David Tse; Chris Alabiad; Sander Dubovy; Prashant K Parekh; Gerald J Harris; Michael Kazim; Payal J Patel; Valerie A White; Peter J Dolman; Bobby S Korn; Don O Kikkawa; Deepak P Edward; Hind M Alkatan; Hailah al-Hussain; R Patrick Yeatts; Dinesh Selva; Patrick Stauffer; Stephen R Planck
Journal:  Exp Mol Pathol       Date:  2015-07-08       Impact factor: 3.362

6.  Increased CD40+ Fibrocytes in Patients With Idiopathic Orbital Inflammation.

Authors:  Brian J Lee; Stephen Atkins; Anna Ginter; Victor M Elner; Christine C Nelson; Raymond S Douglas
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2015 May-Jun       Impact factor: 1.746

7.  Intraorbital injection of Rituximab in idiopathic orbital inflammatory syndrome: case reports.

Authors:  Gustavo Savino; Remo Battendieri; Andrea Siniscalco; Erika Mandarà; Antonino Mulè; Gianluigi Petrone; Salvatore Traina; Monica Riso
Journal:  Rheumatol Int       Date:  2014-05-31       Impact factor: 2.631

8.  Treatment of recalcitrant orbital inflammatory syndrome with plasmapheresis therapy.

Authors:  Yasaira Rodriguez Torres; Fereshteh Azad; Xihui Lin
Journal:  BMJ Case Rep       Date:  2020-01-08

9.  Idiopathic orbital inflammatory disease.

Authors:  Mary K Jacob
Journal:  Oman J Ophthalmol       Date:  2012-05

10.  Role of antimetabolites in recalcitrant idiopathic orbital inflammatory syndrome.

Authors:  Yamini Priya; Suneetha Nithyanandam; Manjoo S Reddy
Journal:  Oman J Ophthalmol       Date:  2011-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.